Observational study reveals higher islet autoantibody positivity in children with obesity, indicating increased susceptibility to type 1 diabetes.
Objectives The prevalence of type 1 diabetes mellitus has increased along with rising incidence of childhood obesity. This study aims to investigate the prevalence of islet-related autoantibodies among obese children in China. Methods The study enrolled patients with moderate to severe obesity aged under 18 years who were admitted between 1 January 2019 and 30 April 2024. Glutamic acid decarboxylase antibody, insulin autoantibody, islet cell autoantibody, zinc transporter 8 autoantibody, and insulinoma-associated protein 2 autoantibody, were measured through chemiluminescent immunoassay. A comparative analysis was conducted of the indicators for glycemic metabolism among the three subgroups, defined according to their autoantibody status. Results Among the 1826 obese children included, 10.9 % were positive for at least one autoantibody, significantly higher than the normal-weight population (1.86 %, p<0.001). Positive results for two autoantibodies were observed in 1.9 % of obese children, statistically higher than in the general population (0.39 %, p<0.01). The HbA 1c level of the two antibody positive groups was statistically higher than that of the antibody negative group (5.8 % vs. 5.6 %, p=0.012). No statistical difference was observed among the three groups regarding anthropometric indicators, biochemical parameters and indicators of glucose metabolism. Conclusions The prevalence of islet-related autoantibodies is higher in obese children, which may contribute to an increasing susceptibility to Type 1 Diabetes Mellitus. The study underscores the necessity for screening in obese children, as this may facilitate early intervention for T1DM.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: